References
- Anand, A., J. Chawla, A. Mahaina, N. Sharma, and N. Khurana. 2017. Therapeutic potential of epigallocatechin gallate. International Journal of Green Pharmacy 11 (3):S364–S70.
- Avadhani, K. S., J. Manikkath, M. Tiwari, M. Chandrasekhar, A. Godavarthi, S. M. Vidya, R. C. Hariharapura, G. Kalthur, N. Udupa, and S. Mutalik. 2017. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Delivery 24 (1):61–74. doi: https://doi.org/10.1080/10717544.2016.1228718.
- Bae, K. H., S. Tan, A. Yamashita, W. X. Ang, S. J. Gao, S. Wang, J. E. Chung, and M. Kurisawa. 2017. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity. Biomaterials 148:41–53. doi: https://doi.org/10.1016/j.biomaterials.2017.09.027.
- Barras, A., A. Mezzetti, A. Richard, S. Lazzaroni, S. Roux, P. Melnyk, D. Betbeder, and N. Monfilliette-Dupont. 2009. Formulation and characterization of polyphenol-loaded lipid nanocapsules. International Journal of Pharmaceutics 379 (2):270–7. doi: https://doi.org/10.1016/j.ijpharm.2009.05.054.
- Chen, C. C., D. S. Hsieh, K. J. Huang, Y. L. Chan, P. D. Hong, M. K. Yeh, and C. J. Wu. 2014. Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells. Drug Design, Development and Therapy 8:459–74. doi: https://doi.org/10.2147/DDDT.S58414.
- Choi, G., T. H. Kim, J. M. Oh, and J. H. Choy. 2018. Emerging nanomaterials with advanced drug delivery functions: Focused on methotrexate delivery. Coordination Chemistry Reviews 359:32–51. doi: https://doi.org/10.1016/j.ccr.2018.01.007.
- Chu, C., J. Deng, Y. Man, and Y. Qu. 2017. Evaluation of nanohydroxyapaptite (nano-HA) coated epigallocatechin-3-gallate (EGCG) cross-linked collagen membranes. Materials Science & Engineering C-Materials for Biological Applications 78:258–64. doi: https://doi.org/10.1016/j.msec.2017.04.069.
- Chung, J. E., S. Tan, S. J. Gao, N. Yongvongsoontorn, S. H. Kim, J. H. Lee, H. S. Choi, H. Yano, L. Zhuo, M. Kurisawa, et al. 2014. Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy. Nature Nanotechnology 9 (11):907–12. doi: https://doi.org/10.1038/nnano.2014.208.
- Dahiya, S., R. Rani, S. Kumar, D. Dhingra, and N. Dilbaghi. 2017. Chitosan-gellan gum bipolymeric nanohydrogels: A potential nanocarrier for the delivery of epigallocatechin gallate. BioNanoScience 7 (3):508–20. doi: https://doi.org/10.1007/s12668-017-0416-0.
- Debnath, K., S. Shekhar, V. Kumar, N. R. Jana, and N. R. Jana. 2016. Efficient inhibition of protein aggregation, disintegration of aggregates, and lowering of cytotoxicity by green tea polyphenol-based self-assembled polymer nanoparticles. ACS Applied Materials & Interfaces 8 (31):20309–18. doi: https://doi.org/10.1021/acsami.6b06853.
- Drew, V. J., H. Y. Huang, Z. H. Tsai, H. H. Tsai, and C. L. Tseng. 2017. Preparation of gelatin/epigallocatechin gallate self-assembly nanoparticles for transdermal drug delivery. Journal of Polymer Research 24 (11):188. doi: https://doi.org/10.1007/s10965-017-1342-0.
- Dube, A., J. A. Nicolazzo, and I. Larson. 2010. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate. European Journal of Pharmaceutical Sciences 41 (2):219–25. doi: https://doi.org/10.1016/j.ejps.2010.06.010.
- Dube, A., J. A. Nicolazzo, and I. Larson. 2011. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. European Journal of Pharmaceutical Sciences 44 (3):422–6. doi: https://doi.org/10.1016/j.ejps.2011.09.004.
- Eng, Q. Y., P. V. Thanikachalam, and S. Ramamurthy. 2018. Molecular understanding of epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases. Journal of Ethnopharmacology 210:296–310. doi: https://doi.org/10.1016/j.jep.2017.08.035.
- Fan, J. X., D. W. Zheng, L. Rong, J. Y. Zhu, S. Hong, C. Li, Z. S. Xu, S. X. Cheng, and X. Z. Zhang. 2017. Targeting epithelial-mesenchymal transition: Metal organic network nano-complexes for preventing tumor metastasis. Biomaterials 139:116–26. doi: https://doi.org/10.1016/j.biomaterials.2017.06.007.
- Fan, Y., Y. Zhang, W. Yokoyama, and J. Yi. 2017. beta-Lactoglobulin-chlorogenic acid conjugate-based nanoparticles for delivery of (-)-epigallocatechin-3-gallate. RSC Advances 7 (35):21366–74. doi: https://doi.org/10.1039/C6RA28462K.
- Fang, J. Y., W. R. Lee, S. C. Shen, and Y. L. Huang. 2006. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. Journal of Dermatological Science 42 (2):101–9. doi: https://doi.org/10.1016/j.jdermsci.2005.12.010.
- Fangueiro, J. F., A. C. Calpena, B. Clares, T. Andreani, M. A. Egea, F. J. Veiga, M. L. Garcia, A. M. Silva, and E. B. Souto. 2016. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. International Journal of Pharmaceutics 502 (1–2):161–9. doi: https://doi.org/10.1016/j.ijpharm.2016.02.039.
- Frias, I., A. R. Neves, M. Pinheiro, and S. Reis. 2016. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation. Drug Design, Development and Therapy 10:3519–28. doi: https://doi.org/10.2147/DDDT.S109589.
- Galati, G., A. Lin, A. M. Sultan, and P. J. O'brien. 2006. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radical Biology and Medicine 40 (4):570–80. doi: https://doi.org/10.1016/j.freeradbiomed.2005.09.014.
- Gan, R. Y., H. B. Li, Z. Q. Sui, and H. Corke. 2018. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Critical Reviews in Food Science and Nutrition 58 (6):924–41. doi: https://doi.org/10.1080/10408398.2016.1231168.
- Gharib, A., Z. Faezizadeh, and M. Godarzee. 2013. Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant Staphylococcus aureus. Skin Pharmacology and Physiology 26 (2):68–75. doi: https://doi.org/10.1159/000345761.
- Gomes, J. F. P. S., S. Rocha, M. D. Pereira, I. Peres, S. Moreno, J. Toca-Herrera, and M. A. N. Coelho. 2010. Lipid/particle assemblies based on maltodextrin-gum arabic core as biocarriers. Colloid Surface B 76 (2):449–55. doi: https://doi.org/10.1016/j.colsurfb.2009.12.004.
- Gómez-Mascaraque, L. G., J. M. Lagarón, and A. López-Rubio. 2015. Electrosprayed gelatin submicroparticles as edible carriers for the encapsulation of polyphenols of interest in functional foods. Food Hydrocolloids 49:42–52. doi: https://doi.org/10.1016/j.foodhyd.2015.03.006.
- Goncalves, V. S. S., J. Poejo, A. A. Matias, S. Rodríguez-Rojo, M. J. Cocero, and C. M. M. Duarte. 2016. Using different natural origin carriers for development of epigallocatechin gallate (EGCG) solid formulations with improved antioxidant activity by PGSS-drying. RSC Advances 6 (72):67599–609. doi: https://doi.org/10.1039/C6RA13499H.
- Granja, A., I. Frias, A. R. Neves, M. Pinheiro, and S. Reis. 2017a. Therapeutic potential of epigallocatechin gallate nanodelivery systems. BioMed Research International 15:5813793. doi: https://doi.org/10.1155/2017/5813793.
- Granja, A., A. C. Vieira, L. L. Chaves, C. Nunes, A. R. Neves, M. Pinheiro, and S. Reis. 2017b. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate. Food Chemistry 237:803–10. doi: https://doi.org/10.1016/j.foodchem.2017.06.019.
- Gülseren, İ., A. Guri, and M. Corredig. 2012. Encapsulation of tea polyphenols in nanoliposomes prepared with milk phospholipids and their effect on the viability of HT-29 human carcinoma cells. Food Digestion 3 (1–3):36–45. doi: https://doi.org/10.1007/s13228-012-0019-8.
- Hong, Z., Y. Xu, J. F. Yin, J. Jin, Y. Jiang, and Q. Du. 2014. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid. Journal of Agricultural and Food Chemistry 62 (52):12603–9. doi: https://doi.org/10.1021/jf504603n.
- Hsieh, D. S., H. C. Lu, C. C. Chen, C. J. Wu, and M. K. Yeh. 2012. The preparation and characterization of gold-conjugated polyphenol nanoparticles as a novel delivery system. International Journal of Nanomedicine 7:1623–33. doi: https://doi.org/10.2147/IJN.S30060.
- Hsieh, D. S., H. Wang, S. W. Tan, Y. H. Huang, C. Y. Tsai, M. K. Yeh, and C. J. Wu. 2011. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Biomaterials 32 (30):7633–40. doi: https://doi.org/10.1016/j.biomaterials.2011.06.073.
- Hu, B., Y. Ting, X. Yang, W. Tang, X. Zeng, and Q. Huang. 2012. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chemical Communications 48 (18):2421–3. doi: https://doi.org/10.1039/c2cc17295j.
- Hu, B., Y. Ting, X. Zeng, and Q. Huang. 2012. Cellular uptake and cytotoxicity of chitosan-caseinophosphopeptides nanocomplexes loaded with epigallocatechin gallate. Carbohydrate Polymers 89 (2):362–70. doi: https://doi.org/10.1016/j.carbpol.2012.03.015.
- Hu, B., Y. W. Ting, X. X. Zeng, and Q. R. Huang. 2013. Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (-)-epigallocatechin-3-gallate. Journal of Agricultural and Food Chemistry 61 (4):875–81. doi: https://doi.org/10.1021/jf304821k.
- Hu, B., Y. Wang, M. H. Xie, G. L. Hu, F. G. Ma, and X. X. Zeng. 2015. Polymer nanoparticles composed with gallic acid grafted chitosan and bioactive peptides combined antioxidant, anticancer activities and improved delivery property for labile polyphenols. Journal of Functional Foods 15:593–603. doi: https://doi.org/10.1016/j.jff.2015.04.009.
- Huang, F., J. Ding, L. Miao, Y. X. Zhao, M. Y. Zhang, C. Chen, G. Wu, S. S. Lin, and F. Wang. 2017. Effects of EGCG on LPS-induced elevation of inflammatory factors in human gingival fibroblasts and functional mechanisms. International Journal of Clinical and Experimental Pathology 10 (5):5580–6.
- Isbrucker, R. A., J. Bausch, J. A. Edwards, and E. Wolz. 2006a. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: Genotoxicity. Food and Chemical Toxicology 44 (5):626–35. doi: https://doi.org/10.1016/j.fct.2005.07.005.
- Isbrucker, R. A., J. A. Edwards, E. Wolz, A. Davidovich, and J. Bausch. 2006b. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies. Food and Chemical Toxicology 44 (5):636–50. doi: https://doi.org/10.1016/j.fct.2005.11.003.
- Isbrucker, R. A., J. A. Edwards, E. Wolz, A. Davidovich, and J. Bausch. 2006c. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats. Food and Chemical Toxicology 44 (5):651–61. doi: https://doi.org/10.1016/j.fct.2005.11.002.
- Jayaramudu, T., K. Varaprasad, G. M. Raghavendra, E. Sadiku, K. M. Raju, and J. Amalraj. 2017. Green synthesis of tea Ag nanocomposite hydrogels via mint leaf extraction for effective antibacterial activity. Journal of Biomaterials Science, Polymer Edition 28 (14):1588–602. doi: https://doi.org/10.1080/09205063.2017.1338501.
- Jiang, Q., C. Song, J. Nangreave, X. W. Liu, L. Lin, D. L. Qiu, Z. G. Wang, G. Z. Zou, X. J. Liang, H. Yan, and B. Q. Ding. 2012. DNA origami as a carrier for circumvention of drug resistance. Journal of the American Chemical Society 134 (32):13396–403. doi: https://doi.org/10.1021/ja304263n.
- Khan, N., D. J. Bharali, V. M. Adhami, I. A. Siddiqui, H. Cui, S. M. Shabana, S. A. Mousa, and H. Mukhtar. 2014. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis 35 (2):415–23. doi: https://doi.org/10.1093/carcin/bgt321.
- Khoobchandani, M., K. Katti, A. Maxwell, W. P. Fay, and K. V. Katti. 2016. Laminin receptor-avid nanotherapeutic EGCG-AuNPs as a potential alternative therapeutic approach to prevent restenosis. International Journal of Molecular Sciences 17 (3):316. doi: https://doi.org/10.3390/ijms17030316.
- Kim, Y. J., M. R. Park, M. S. Kim, and O. H. Kwon. 2012. Polyphenol-loaded polycaprolactone nanofibers for effective growth inhibition of human cancer cells. Materials Chemistry and Physics 133 (2–3):674–80. doi: https://doi.org/10.1016/j.matchemphys.2012.01.050.
- Koutelidakis, A. E., K. Argyri, Z. Sevastou, D. Lamprinaki, E. Panagopoulou, E. Paximada, A. Sali, V. Papalazarou, A. Mallouchos, V. Evageliou, et al. 2017. Bioactivity of epigallocatechin gallate nanoemulsions evaluated in mice model. Journal of Medicinal Food 20 (9):923–31. doi: https://doi.org/10.1089/jmf.2016.0160.
- Krupkova, O., S. J. Ferguson, and K. Wuertz-Kozak. 2016. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. The Journal of Nutritional Biochemistry 37:1–12. doi: https://doi.org/10.1016/j.jnutbio.2016.01.002.
- Kulandaivelu, K., and A. K. A. Mandal. 2017. Improved bioavailability and pharmacokinetics of tea polyphenols by encapsulation into gelatin nanoparticles. IET Nanobiotechnology 11 (4):469–76. doi: https://doi.org/10.1049/iet-nbt.2016.0147.
- Kumar, S. A., M. Suresh, S. N. K. Kumar, and P. Kalaiselvi. 2013. Synthesis and characterization of major green tea catechin nanoparticle. Asian Journal of Chemistry 25:S343–S6.
- Lee, M. J., P. Maliakal, L. Chen, X. Meng, F. Y. Bondoc, S. Prabhu, G. Lambert, S. Mohr, and C. S. Yang. 2002. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans formation of different metabolites and individual variability. Cancer Epidemiology, Biomarkers & Prevention 11 (10):1025–32.
- Lee, S., G. S. Al Razqan, and D. H. Kwon. 2017. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with beta-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Phytomedicine 24:49–55. doi: https://doi.org/10.1016/j.phymed.2016.11.007.
- Li, B., W. Du, J. Jin, and Q. Du. 2012. Preservation of (-)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated β-lactoglobulin nanoparticles. Journal of Agricultural and Food Chemistry 60 (13):3477–84. doi: https://doi.org/10.1021/jf300307t.
- Li, F., C. Gao, P. Yan, M. Zhang, Y. Wang, Y. Hu, X. Wu, X. Wang, and J. Sheng. 2018. EGCG reduces obesity and white adipose tissue gain partly through AMPK activation in mice. Frontiers in Pharmacology 9:1366. doi: https://doi.org/10.3389/fphar.2018.01366.
- Liang, J., L. Cao, L. Zhang, and X. C. Wan. 2014. Preparation, characterization, and in vitro antitumor activity of folate conjugated chitosan coated EGCG nanoparticles. Food Science and Biotechnology 23 (2):569–75. doi: https://doi.org/10.1007/s10068-014-0078-4.
- Liang, J., H. Yan, X. L. Wang, Y. B. Zhou, X. L. Gao, P. Puligundla, and X. C. Wan. 2017. Encapsulation of epigallocatechin gallate in zein/chitosan nanoparticles for controlled applications in food systems. Food Chemistry 231:19–24. doi: https://doi.org/10.1016/j.foodchem.2017.02.106.
- Liang, J., H. Yan, H. J. Yang, H. W. Kim, X. C. Wan, J. Lee, and S. Ko. 2016. Synthesis and controlled-release properties of chitosan/beta-lactoglobulin nanoparticles as carriers for oral administration of epigallocatechin gallate. Food Science and Biotechnology 25 (6):1583–90. doi: https://doi.org/10.1007/s10068-016-0244-y.
- Liang, R., L. Chen, W. Yokoyama, P. A. Williams, and F. Zhong. 2016. Niosomes consisting of Tween-60 and cholesterol improve the chemical stability and antioxidant activity of (-)-epigallocatechin gallate under intestinal tract conditions. Journal of Agricultural and Food Chemistry 64 (48):9180–8. doi: https://doi.org/10.1021/acs.jafc.6b04147.
- Liao, B., Ying, H. C. Yu, Z. Fan, W. Zhang, J. Shi, H. Ying, N. Ravichandran, Y. Xu, J. Yin, Y., et al. 2016. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice. International Journal of Pharmaceutics 512 (1):22–31. doi: https://doi.org/10.1016/j.ijpharm.2016.08.038.
- Lin, Y. H., C. L. Feng, C. H. Lai, J. H. Lin, and H. Y. Chen. 2014. Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo. Science and Technology of Advanced Materials 15 (4):045006. doi: https://doi.org/10.1088/1468-6996/15/4/045006.
- Liu, H. C., L. L. Yu, X. Y. Dong, and Y. Sun. 2017. Synergistic effects of negatively charged hydrophobic nanoparticles and (-)-epigallocatechin-3-gallate on inhibiting amyloid beta-protein aggregation. Journal of Colloid and Interface Science 491:305–12. doi: https://doi.org/10.1016/j.jcis.2016.12.038.
- Liu, S., L. Yang, S. Mu, and Q. Fu. 2018. Epigallocatechin-3-gallate ameliorates glucocorticoid-induced osteoporosis of rats in vivo and in vitro. Frontiers in Pharmacology 9:447. doi: https://doi.org/10.3389/fphar.2018.00447.
- Lu, Y. C., P. C. Luo, C. W. Huang, Y. L. Leu, T. H. Wang, K. C. Wei, H. E. Wang, and Y. H. Ma. 2014. Augmented cellular uptake of nanoparticles using tea catechins: Effect of surface modification on nanoparticle-cell interaction. Nanoscale 6 (17):10297–306. doi: https://doi.org/10.1039/C4NR00617H.
- Luo, T., J. Wang, Y. Yin, H. Hua, J. Jing, X. Sun, M. Li, Y. Zhang, and Y. Jiang. 2010. (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Research 12 (1):R8. doi: https://doi.org/10.1186/bcr2473.
- Luo, X., R. Guan, X. Chen, M. Tao, J. Ma, and J. Zhao. 2014. Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells. Nanoscale Research Letters 9 (1):291. doi: https://doi.org/10.1186/1556-276X-9-291.
- Mazzanti, G., F. Menniti-Ippolito, P. A. Moro, F. Cassetti, R. Raschetti, C. Santuccio, and S. Mastrangelo. 2009. Hepatotoxicity from green tea: A review of the literature and two unpublished cases. European Journal of Clinical Pharmacology 65 (4):331–41. doi: https://doi.org/10.1007/s00228-008-0610-7.
- Mereles, D., and W. Hunstein. 2011. Epigallocatechin-3-gallate (EGCG) for clinical trials: More pitfalls than promises? International Journal of Molecular Sciences 12 (9):5592–603. doi: https://doi.org/10.3390/ijms12095592.
- Moreno-Vásquez, M. J., M. Plascencia-Jatomea, S. Sánchez-Valdes, F. J. Castillo-Yáñez, V. M. Ocaño-Higuera, F. Rodríguez-Félix, E. C. Rosas-Burgos, and A. Z. Graciano-Verdugo. 2017. Preparation and characterization of films made of poly (L-lactic acid)/poly (L-lactic acid) grafted maleic anhydride/epigallocatechin gallate blends for antibacterial food packaging. Journal of Plastic Film & Sheeting 33 (1):10–34. doi: https://doi.org/10.1177/8756087916631602.
- Mukherjee, S., S. Ghosh, D. K. Das, P. Chakraborty, S. Choudhury, P. Gupta, A. Adhikary, S. Dey, and S. Chattopadhyay. 2015. Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection: Synthesis, characterization and in vitro evaluation. The Journal of Nutritional Biochemistry 26 (11):1283–97. doi: https://doi.org/10.1016/j.jnutbio.2015.06.003.
- Nagle, D. G., D. Ferreira, and Y. D. Zhou. 2006. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 67 (17):1849–55. doi: https://doi.org/10.1016/j.phytochem.2006.06.020.
- Narayanan, S., U. Mony, D. K. Vijaykumar, M. Koyakutty, B. Paul-Prasanth, and D. Menon. 2015. Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells. Nanomedicine: Nanotechnology, Biology and Medicine 11 (6):1399–406. doi: https://doi.org/10.1016/j.nano.2015.03.015.
- Narayanan, S., M. Pavithran, A. Viswanath, D. Narayanan, C. C. Mohan, K. Manzoor, and D. Menon. 2014. Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: Design, synthesis, biocompatibility and pharmacokinetics. Acta Biomaterialia 10 (5):2112–24. doi: https://doi.org/10.1016/j.actbio.2013.12.041.
- Nigam, S., and D. Bahadur. 2016. Dendrimerized magnetic nanoparticles as carriers for the anticancer compound, epigallocatechin gallate. IEEE Transactions on Magnetics 52 (6):1. doi: https://doi.org/10.1109/TMAG.2016.2517602.
- Pae, M., Z. Ren, M. Meydani, F. Shang, D. Smith, S. N. Meydani, and D. Wu. 2012. Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice. The Journal of Nutritional Biochemistry 23 (6):526–31. doi: https://doi.org/10.1016/j.jnutbio.2011.02.006.
- Pal, S., and C. Saha. 2015. Preparation and physicochemical characterization of poly (D, L-lactide-co-glycolide) nanoparticles for controlled release of EGCG. International Journal of Science and Research (IJSR) 4:862–5.
- Park, S. J., C. V. Garcia, G. H. Shin, and J. T. Kim. 2016. Fabrication and optimization of EGCG-loaded nanoparticles by high pressure homogenization. Journal of Applied Polymer Science 133 (14). doi: https://doi.org/10.1002/app.43269.
- Paximada, P., Y. Echegoyen, A. A. Koutinas, I. G. Mandala, and J. M. Lagaron. 2017. Encapsulation of hydrophilic and lipophilized catechin into nanoparticles through emulsion electrospraying. Food Hydrocolloids 64:123–32. doi: https://doi.org/10.1016/j.foodhyd.2016.11.003.
- Peres, I., S. Rocha, J. Gomes, S. Morais, M. C. Pereira, and M. Coelho. 2011. Preservation of catechin antioxidant properties loaded in carbohydrate nanoparticles. Carbohydrate Polymers 86 (1):147–53. doi: https://doi.org/10.1016/j.carbpol.2011.04.029.
- Prinsloo, G., C. K. Marokane, and R. A. Street. 2018. Anti-HIV activity of Southern African plants: Current developments, phytochemistry and future research. Journal of Ethnopharmacology 210:133–55. doi: https://doi.org/10.1016/j.jep.2017.08.005.
- Radhakrishnan, R., H. Kulhari, D. Pooja, S. Gudem, S. Bhargava, R. Shukla, and R. Sistla. 2016. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chemistry and Physics of Lipids 198:51–60. doi: https://doi.org/10.1016/j.chemphyslip.2016.05.006.
- Ramadass, S. K., N. V. Anantharaman, S. Subramanian, S. Sivasubramanian, and B. Madhan. 2015. Paclitaxel/epigallocatechin gallate coloaded liposome: A synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells. Colloids and Surfaces B: Biointerfaces 125:65–72. doi: https://doi.org/10.1016/j.colsurfb.2014.11.005.
- Rashidinejad, A., E. J. Birch, D. Sun-Waterhouse, and D. W. Everett. 2014. Delivery of green tea catechin and epigallocatechin gallate in liposomes incorporated into low-fat hard cheese. Food Chemistry 156:176–83. doi: https://doi.org/10.1016/j.foodchem.2014.01.115.
- Rashidinejad, A., E. J. Birch, D. Sun-Waterhouse, and D. W. Everett. 2016. Effect of liposomal encapsulation on the recovery and antioxidant properties of green tea catechins incorporated into a hard low-fat cheese following in vitro simulated gastrointestinal digestion. Food and Bioproducts Processing 100:238–45. doi: https://doi.org/10.1016/j.fbp.2016.07.005.
- Rocha, S., R. Generalov, M. D. Pereira, I. Peres, P. Juzenas, and M. A. N. Coelho. 2011. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine 6 (1):79–87. doi: https://doi.org/10.2217/nnm.10.101.
- Sanna, V., G. Pintus, A. M. Roggio, S. Punzoni, A. M. Posadino, A. Arca, S. Marceddu, P. Bandiera, S. Uzzau, and M. Sechi. 2011. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. Journal of Medicinal Chemistry 54 (5):1321–32. doi: https://doi.org/10.1021/jm1013715.
- Sanna, V., C. K. Singh, R. Jashari, V. M. Adhami, J. C. Chamcheu, I. Rady, M. Sechi, H. Mukhtar, and I. A. Siddiqui. 2017. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Scientific Reports 7:41573. doi: https://doi.org/10.1038/srep41573.
- Schmidt, B. M., D. M. Ribnicky, P. E. Lipsky, and I. Raskin. 2007. Revisiting the ancient concept of botanical therapeutics. Nature Chemical Biology 3 (7):360–6. doi: https://doi.org/10.1038/nchembio0707-360.
- Seo, Y., J. Leong, J. Y. Teo, J. W. Mitchell, M. U. Gillette, B. Han, J. Lee, and H. Kong. 2017. Active antioxidizing particles for on-demand pressure-driven molecular release. ACS Applied Materials & Interfaces 9 (41):35642–50. doi: https://doi.org/10.1021/acsami.7b12297.
- Shafiei, S. S., M. Solati-Hashjin, A. Samadikuchaksaraei, R. Kalantarinejad, M. Asadi-Eydivand, and N. A. Abu Osman. 2015. Epigallocatechin gallate/layered double hydroxide nanohybrids: Preparation, characterization, and in vitro anti-tumor study. PLoS One 10 (8):e0136530. doi: https://doi.org/10.1371/journal.pone.0136530.
- Sheng, L., P. K. Jena, H. X. Liu, Y. Hu, N. Nagar, D. N. Bronner, M. L. Settles, A. J. Baumler, and Y. J. Wan. 2018. Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila. FASEB J 32 (12):6371–84. doi: https://doi.org/10.1096/fj.201800370R.
- Shetty, P. K., J. Manikkath, K. Tupally, G. Kokil, A. R. Hegde, S. Y. Raut, H. S. Parekh, and S. Mutalik. 2017. Skin delivery of EGCG and silibinin: Potential of peptide dendrimers for enhanced skin permeation and deposition. AAPS PharmSciTech 18 (6):2346–57. doi: https://doi.org/10.1208/s12249-017-0718-0.
- Shin, Y. C., W. J. Yang, J. H. Lee, J. W. Oh, T. W. Kim, J. C. Park, S. H. Hyon, and D. W. Han. 2014. PLGA nanofiber membranes loaded with epigallocatechin-3-O-gallate are beneficial to prevention of postsurgical adhesions. International Journal of Nanomedicine 9:4067–78. doi: https://doi.org/10.2147/ijn.s68197.
- Shpigelman, A., Y. Cohen, and Y. D. Livney. 2012. Thermally-induced β-lactoglobulin–EGCG nanovehicles: Loading, stability, sensory and digestive-release study. Food Hydrocolloids 29 (1):57–67. doi: https://doi.org/10.1016/j.foodhyd.2012.01.016.
- Shpigelman, A., G. Israeli, and Y. D. Livney. 2010. Thermally-induced protein-polyphenol co-assemblies: Beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG. Food Hydrocolloids 24 (8):735–43. doi: https://doi.org/10.1016/j.foodhyd.2010.03.015.
- Shukla, R., N. Chanda, A. Zambre, A. Upendran, K. Katti, R. R. Kulkarni, S. K. Nune, S. W. Casteel, C. J. Smith, J. Vimal., et al. 2012. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCG) show efficacy in treating prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 109 (31):12426–31. doi: https://doi.org/10.1073/pnas.1121174109.
- Shutava, T. G., S. S. Balkundi, and Y. M. Lvov. 2009. (-)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsules. Journal of Colloid and Interface Science 330 (2):276–83. doi: https://doi.org/10.1016/j.jcis.2008.10.082.
- Shutava, T. G., S. S. Balkundi, P. Vangala, J. J. Steffan, R. L. Bigelow, J. A. Cardelli, D. P. O’Neal, and Y. M. Lvov. 2009. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano 3 (7):1877–85. doi: https://doi.org/10.1021/nn900451a.
- Siddiqui, I. A., V. M. Adhami, N. Ahmad, and H. Mukhtar. 2010. Nanochemoprevention: Sustained release of bioactive food components for cancer prevention. Nutrition and Cancer 62 (7):883–90. doi: https://doi.org/10.1080/01635581.2010.509537.
- Siddiqui, I. A., V. M. Adhami, D. J. Bharali, B. B. Hafeez, M. Asim, S. I. Khwaja, N. Ahmad, H. D. Cui, S. A. Mousa, and H. Mukhtar. 2009. Introducing nanochemoprevention as a novel approach for cancer control: Proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Research 69 (5):1712–6. doi: https://doi.org/10.1158/0008-5472.CAN-08-3978.
- Siddiqui, I. A., D. J. Bharali, M. Nihal, V. M. Adhami, N. Khan, J. C. Chamcheu, M. I. Khan, S. Shabana, S. A. Mousa, and H. Mukhtar. 2014. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine 10 (8):1619–26. doi: https://doi.org/10.1016/j.nano.2014.05.007.
- Siddiqui, I. A., D. J. Bharali, M. Nihal, V. M. Adhami, N. Khan, J. C. Chamcheu, M. I. Khan, S. Shabana, S. A. Mousa, and H. Mukhtar. 2014. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine: Nanotechnology, Biology and Medicine 10 (8):1619–26. doi: https://doi.org/10.1016/j.nano.2014.05.007.
- Singh, M., P. Bhatnagar, S. Mishra, P. Kumar, Y. Shukla, and K. C. Gupta. 2015. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma. International Journal of Nanomedicine 10:6789–809. doi: https://doi.org/10.2147/IJN.S79489.
- Singh, N. A., A. K. A. Mandal, and Z. A. Khan. 2016. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Journal of Nutrition 15 (1):60. doi: https://doi.org/10.1186/s12937-016-0179-4.
- Smith, A., B. Giunta, P. C. Bickford, M. Fountain, J. Tan, and R. D. Shytle. 2010. Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease. International Journal of Pharmaceutics 389 (1–2):207–12. doi: https://doi.org/10.1016/j.ijpharm.2010.01.012.
- Song, Q., D. Li, Y. Zhou, J. Yang, W. Yang, G. Zhou, and J. Wen. 2014. Enhanced uptake and transport of (+)-catechin and (-)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells. International Journal of Nanomedicine 9:2157. doi: https://doi.org/10.2147/IJN.S59331.
- Soppimath, K. S., T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 70 (1–2):1–20. (00)00339-4. doi: https://doi.org/10.1016/S0168-3659.
- Syarifah-Noratiqah, S. B., I. Naina-Mohamed, M. S. Zulfarina, and H. M. S. Qodriyah. 2018. Natural polyphenols in the treatment of Alzheimer’s disease. Current Drug Targets 19 (8):927–37. doi: https://doi.org/10.2174/1389450118666170328122527.
- Srivastava, A. K., P. Bhatnagar, M. Singh, S. Mishra, P. Kumar, Y. Shukla, and K. C. Gupta. 2013. Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage. International Journal of Nanomedicine 8:1451–62. doi: https://doi.org/10.2147/IJN.S26364.
- Tang, D. W., S. H. Yu, Y. C. Ho, B. Q. Huang, G. J. Tsai, H. Y. Hsieh, H. W. Sung, and F. L. Mi. 2013. Characterization of tea catechins-loaded nanoparticles prepared from chitosan and an edible polypeptide. Food Hydrocolloids 30 (1):33–41. doi: https://doi.org/10.1016/j.foodhyd.2012.04.014.
- Tian, J., H. Tu, X. Shi, X. Wang, H. Deng, B. Li, and Y. Du. 2016. Antimicrobial application of nanofibrous mats self-assembled with chitosan and epigallocatechin gallate. Colloids and Surfaces B: Biointerfaces 145:643–52. doi: https://doi.org/10.1016/j.colsurfb.2016.05.008.
- Wang, D., E. W. Taylor, Y. Wang, X. Wan, and J. Zhang. 2012. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention. International Journal of Nanomedicine 7:1711–21. doi: https://doi.org/10.2147/IJN.S29341.
- Wang, H., Y. Zhao, Y. Wu, Y. L. Hu, K. Nan, G. Nie, and H. Chen. 2011. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32 (32):8281–90. doi: https://doi.org/10.1016/j.biomaterials.2011.07.032.
- Wang, X., Y. Xie, H. Ge, L. Chen, J. Wang, S. Zhang, Y. Guo, Z. Li, and X. Feng. 2018. Physical properties and antioxidant capacity of chitosan/epigallocatechin-3-gallate films reinforced with nano-bacterial cellulose. Carbohydrate Polymers 179:207–20. doi: https://doi.org/10.1016/j.carbpol.2017.09.087.
- Wasai, M., H. Nonaka, M. Murata, R. Kitamura, Y. Sato, and H. Tachibana. 2018. Long-term dietary supplementation with the green tea cultivar Sunrouge prevents age-related cognitive decline in the senescence-accelerated mouse Prone8. Bioscience, Biotechnology, and Biochemistry. doi: https://doi.org/10.1080/09168451.2018.1530093.
- Wu, Y. R., H. J. Choi, Y. G. Kang, J. K. Kim, and J. W. Shin. 2017. In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles. International Journal of Nanomedicine 12:7007–13. doi: https://doi.org/10.2147/IJN.S146296.
- Xi, J., Q. Li, X. Luo, J. Li, L. Guo, H. Xue, and G. Wu. 2018. Epigallocatechin-3-gallate protects against secondary osteoporosis in a mouse model via the Wnt/beta-catenin signaling pathway. Molecular Medicine Reports 18 (5):4555–62. .
- Xicota, L., J. Rodríguez-Morató, M. Dierssen, and R. de la Torre. 2017. Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease. Current Drug Targets 18 (2):174–95. doi: https://doi.org/10.2174/1389450116666150825113655.
- Yang, C. S., L. Chen, M. J. Lee, D. Balentine, M. C. Kuo, and S. P. Schantz. 1998. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiology, Biomarkers & Prevention 7 (4):351–4.
- Yang, R., Y. Liu, Y. Gao, Y. Wang, C. Blanchard, and Z. Zhou. 2017. Ferritin glycosylated by chitosan as a novel EGCG nano-carrier: Structure, stability, and absorption analysis. International Journal of Biological Macromolecules 105:252–61. doi: https://doi.org/10.1016/j.ijbiomac.2017.07.040.
- Yang, R., Y. Q. Liu, D. M. Meng, Z. Y. Chen, C. L. Blanchard, and Z. K. Zhou. 2017. Urea-driven epigallocatechin gallate (EGCG) permeation into the ferritin cage, an innovative method for fabrication of protein-polyphenol co-assemblies. Journal of Agricultural and Food Chemistry 65 (7):1410–9. doi: https://doi.org/10.1021/acs.jafc.6b04671.
- Yang, Y. Y., Jin, P. X. C. Zhang, N. Ravichandran, H. Ying, C. H. Yu, H. Z. Ying, Y. Q. Xu, J. F. Yin, K. Wang, M., et al. 2017. New epigallocatechin gallate (EGCG) nanocomplexes co-assembled with 3-mercapto-1-hexanol and beta-lactoglobulin for improvement of antitumor activity. Journal of Biomedical Nanotechnology 13 (7):805–14. doi: https://doi.org/10.1166/jbn.2017.2400.
- Yin, Y. Y., L. L. Cui, F. L. Yan, Z. Z. Zhang, W. J. Li, and L. Wang. 2017. Epigallocatechin gallate based magnetic gold nanoshells nanoplatform for cancer theranostic applications. Journal of Materials Chemistry B 5 (3):454–63. doi: https://doi.org/10.1039/C6TB02408D.
- Yokotani, K., and K. Umegaki. 2017. Evaluation of plasma antioxidant activity in rats given excess EGCG with reference to endogenous antioxidants concentrations and assay methods. Free Radical Research 51 (2):193–9. doi: https://doi.org/10.1080/10715762.2017.1291941.
- Zeng, L., J. Yan, L. Luo, M. Ma, and H. Zhu. 2017. Preparation and characterization of (-)-epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on human breast cancer MCF-7 cells. Scientific Reports 7:45521. doi: https://doi.org/10.1038/srep45521.
- Zhan, W., Y. Liu, D. P. Li, and Y. Liu. 2016. Advancing insights on the anti-obesity biochemical mechanism of (-)-epigallocatechin gallate (EGCG) by inhibiting alpha-amylase activity. RSC Advances 6 (99):96918–27. doi: https://doi.org/10.1039/C6RA20750B.
- Zhang, H., S. Su, X. Yu, and Y. Li. 2017. Dietary epigallocatechin 3-gallate supplement improves maternal and neonatal treatment outcome of gestational diabetes mellitus: A double-blind randomised controlled trial. Journal of Human Nutrition and Dietetics 30 (6):753–8. doi: https://doi.org/10.1111/jhn.12470.
- Zhang, J., S. Nie, R. Martinez-Zaguilan, S. R. Sennoune, and S. Wang. 2016. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles. The Journal of Nutritional Biochemistry 30:14–23. doi: https://doi.org/10.1016/j.jnutbio.2015.11.001.
- Zhang, J., S. F. Nie, and S. Wang. 2013. Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages. Journal of Agricultural and Food Chemistry 61 (38):9200–9. doi: https://doi.org/10.1021/jf4023004.
- Zhang, J., X. Zhou, Q. Yu, L. Yang, D. Sun, Y. Zhou, and J. Liu. 2014. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity. ACS Applied Materials & Interfaces 6 (11):8475–87. doi: https://doi.org/10.1002/9781118856017.ch8.
- Zhang, L., S. Wu, D. Wang, X. Wan, and J. Zhang. 2014. Epigallocatechin-3-gallate (EGCG) in or on nanoparticles: Enhanced stability and bioavailability of EGCG encapsulated in nanoparticles or targeted delivery of gold nanoparticles coated with EGCG. In Handbook of nanotoxicology, nanomedicine and stem cell use in toxicology, edited by S. C. Sahu and D. A. Casciano, 131–144. Hoboken, NJ: John Wiley & Sons. doi: https://doi.org/10.1002/9781118856017.ch8.
- Zhang, W. H., Y. Y. Yang, T. Lv, Z. Y. Fan, Y. Q. Xu, J. F. Yin, B. W. Liao, H. Ying, N. Ravichandran, and Q. Z. Du. 2017. Sucrose esters improve the colloidal stability of nanoethosomal suspensions of (-)-epigallocatechin gallate for enhancing the effectiveness against UVB-induced skin damage. Journal of Biomedical Materials Research Part B: Applied Biomaterials 105 (8):2416–25. doi: https://doi.org/10.1002/jbm.b.33785.
- Zhou, T., M. Zhu, and Z. Liang. 2018. (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson’s disease. Molecular Medicine Reports 17 (4):4883–8. doi: https://doi.org/10.3892/mmr.2018.8470.
- Zou, L., S. Peng, W. Liu, X. Chen, and C. Liu. 2015. A novel delivery system dextran sulfate coated amphiphilic chitosan derivatives-based nanoliposome: Capacity to improve in vitro digestion stability of (-)-epigallocatechin gallate. Food Research International 69:114–20. doi: https://doi.org/10.1016/j.foodres.2014.12.015.
- Zou, L. Q., S. F. Peng, W. Liu, L. Gan, W. L. Liu, R. H. Liang, C. M. Liu, J. Niu, Y. L. Cao, Z. Liu, and X. Chen. 2014. Improved in vitro digestion stability of (-)-epigallocatechin gallate through nanoliposome encapsulation. Food Research International 64:492–9. doi: https://doi.org/10.1016/j.foodres.2014.07.042.